S0888 Alternative Subcutaneous Biologic Dosing in Inflammatory Bowel Disease Is Delayed Depending on Insurance Approval Requirements. (October 2020) - Coe, Christopher; Cherry, Laura; Shah, Nisha; Zuckerman, Autumn D.; DeClercq, Joshua; Choi, Leena; Donoho, Charles; Pabla, Baldeep S.; Scoville, Elizabeth; Dalal, Robin; Beaulieu, Dawn; Schwartz, David A.; et al.